PropelRx Ltd
PropelRx provides a structured fundraising operating system that diagnoses readiness, aligns capital, and executes outreach with institutional discipline for Seed to Series B startups.
At a Glance
- Seed to Series B Startups
- Early-stage Founders
- Venture Capital backed companies
AI Tools by PropelRx Ltd
(1)
PropelRx
Startup Capital Readiness Platform
Discussions
No discussions yet
Be the first to start a discussion about PropelRx Ltd
Latest News
PropelRx: Fundraising tools are broken. Here's the fix. (LinkedIn Announcement)
Startups adapt to profitability-driven VC landscape: PropelRx seeing pivot towards unit economics in pitch automation.
PropelRx Milestone: Over 45 companies running live capital campaigns inside the platform.
PropelRx announces upcoming launch on Product Hunt.
Products & Services
Investor matching platform including firm names, partners, thesis alignment breakdown, and check size/stage fit scoring.
Comprehensive fundraising execution engine with automated outreach sequences, engagement tracking, and data room gating.
Diagnostic tool that generates a readiness score across financial, narrative, structural, timing, and reputational dimensions.
Market Position
PropelRx positions itself as a 'structured fundraising operating system' contrasting with 'unstructured' fundraising chaos. It focuses on institutional discipline, readiness scoring, and precise alignment rather than bulk outreach.
Leadership
Founders
Jamal Hirani
Former Venture Capital professional who deployed over £200M across 50+ portfolio companies. 20+ years as a founder raising and deploying £100M+ across sectors like Food, Gaming, Fintech, and Retail. Education: Aston University.
Executive Team
Jamal Hirani
Founder
Former VC and operator with 20+ years experience in fundraising and investment deployment.
Permjit Hirani
Director / Co-Founder
Director of Propeligent Ltd, involved in operational management.
Founding Story
Founder Jamal Hirani, a former VC who deployed over £200M, saw that many brilliant founders failed to raise because of poor preparation and misaligned targeting. He founded PropelRx to provide founders with the 'institutional discipline' and alignment data necessary to succeed in a competitive VC landscape.
Business Model
Revenue Model
Subscription model ($62/mo for Institutional Access, $199/mo for Campaign Execution) plus a 3.95% success fee (capped at $200K) when funding is secured. No equity is taken.
Pricing Tiers
Full investor firm names & partners, thesis alignment breakdown, stage fit scoring, basic outreach activation.
Automated outreach sequences, engagement tracking, data room gating, meeting scheduling infrastructure.
Dedicated support, multi-raise coordination, and custom solutions for growth-stage companies.
Target Markets
- Seed to Series B Startups
- Early-stage Founders
- Venture Capital backed companies
- Seed to Series B startups raising capital
- Founders looking to automate investor outreach
- Startups needing to diagnose capital readiness
- Precision targeting of aligned VC investors
- Over 45 companies running live capital campaigns